Antibody responses and persistence in the two years after immunization with two acellular vaccines and one whole-cell vaccine against pertussis

This publication has 15 references indexed in Scilit:

• The Seroepidemiology of Bordetella pertussis Infections: A Study of Persons Ages 1-65 Years
  The Journal of Infectious Diseases, 1996
• Acellular pertussis vaccine as a booster dose for seventeen- to nineteen-month-old children immunized with either whole cell or acellular pertussis vaccine at two, four and six months of age
  The Pediatric Infectious Disease Journal, 1995
• Antibody response to accelerated immunisation with diphtheria, tetanus, pertussis vaccine
  The Lancet, 1993
• Acellular Pertussis Vaccines—A Solution to the Pertussis Problem?
  The Journal of Infectious Diseases, 1993
• Relative efficacy of two acellular pertussis vaccines during three years of passive surveillance
  Vaccine, 1992
• Persistence of antibody after accelerated immunisation with diphtheria/tetanus/pertussis vaccine.
  BMJ, 1991
• Characterization of the protective capacity and immunogenicity of the 69-kD outer membrane protein of Bordetella pertussis.
  The Journal of Experimental Medicine, 1989
• PLACEBO-CONTROLLED TRIAL OF TWO ACELLULAR PERTUSSIS VACCINES IN SWEDEN—PROTECIVE EFFICACY AND ADVERSE EVENTS
  The Lancet, 1988
• Duration of effectiveness of pertussis vaccine: evidence from a 10 year community study
  BMJ, 1988
• Protective Activities of the Filamentous Hemagglutinin and the Lymphocytosis-Promoting Factor of Bordetella pertussis in Mice
  The Journal of Infectious Diseases, 1984